It's quite a leap to go from the study you linked to thinking AI will create models that will be useful for new trials. The big leaps in AI have required enormous amounts of data. There is no such analogous data sets in biology and no foreseeable way to get it.

It really is hard to see AI improving the trial process meaningfully. We are more likely to see progress with better trial design and regulatory regimes.